Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia
ConditionAndrogenetic Alopecia
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexMale
Age18-60
SponsorEMS
About this trial
The purpose of this study is to evaluate the efficacy of Finlândia hair lotion association in the treatment of androgenetic alopecia.
Eligibility criteria
Qualifiers
Ability to confirm voluntary participation and agree to all trial purposes by signing and dating the informed consent forms;
Men aged 18 years or over and less than or equal to 60 years with a diagnosis of Androgenetic Alopecia grades IIIv to IV in the modified Norwood-Hamilton classification, who have been using minoxidil 5% for at least 3 months and willing to maintain the same style, approximate length and hair color throughout the test.
Disqualifiers
Known hypersensitivity to the formula components used during the clinical trial;
History of alcohol and/or substance abuse within 2 years;
Participants with other concomitant dermatological diseases on the scalp, except for mild seborrhoea dermatitis;
Participants with a history of surgical treatment for hair loss or shaved scalp;
Trial design
Treatments tested in this trial
- Finlândia Association + finasteride placebo
- Minoxidil + finasteride
Treatment groups
190 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov